Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Kirkland's, Inc. (KIRK - Analyst Report) has announced the sales and comparable sales for two months of the first quarter of fiscal 2012.
Net sales for the nine-week period ended March 31, 2012 jumped 3.4% to $71.4 million from $69.0 million for the nine-week period ended April 2, 2011. Kirkland’s comparable store sales declined 1.3% for the same period as against the decrease of 8.9% in the prior-year period.
Kirkland’s expects to report its earnings results for the first quarter of fiscal 2012 ending April 28, 2012 on May 18, 2012. The company expects sales in the range of $98 - $100 million and anticipated that comparable store sales would be flat to slightly positive for the first quarter of fiscal 2012.
In early-March, Kirkland's reported its results for the fourth-quarter of fiscal 2011 (ending January 28, 2012). The company reported earnings of 78 cents per share, which were ahead of the Zacks Consensus Estimate of 74 cents per share and the prior-year earnings of 70 cents per share. Kirkland’s earnings for the full fiscal year 2011 were 95 cents per share. The results surpassed the Zacks Consensus estimate of 91 cents, but were well below the year-ago earnings of $1.28 per share.
Kirkland’s net sales went up 6.8% year over year to $149.1 million in the quarter from $139.6 million in the year-ago quarter, while sales upped 3.6% year over year to $430.0 million in fiscal 2011.
Consolidated comparable store sales increased 1.4% in the fourth quarter 2011 as compared to a 7.9% decrease in the prior-year quarter. However, comparable store sales in fiscal 2011 decreased 4.0% compared with a 0.5% decrease in fiscal 2010.
Currently, we provide a Zacks #3 Rank (short-term ‘Hold’ rating) on Kirkland’s, which competes with Bed Bath & Beyond Inc. (BBBY - Analyst Report).
Read the full Analyst Report on BBBY
Read the full Analyst Report on KIRK